Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study
Merck & Co., Inc., Rahway, NJ, USA (United States) · Albert Einstein College of Medicine · +2 more institutions
Abstract
Though symptomatic medication overuse is believed to play a major role in progression from episodic to chronic or transformed migraine (TM), population-based longitudinal data on these agents are limited.
To assess the role of specific classes of acute medications in the development of TM in episodic migraine (EM) sufferers after adjusting for other risk factors for headache progression.
Citation impact
- FWCI
- 22.05
- Percentile
- 100%
- References
- 36
Authors
6- MEMarcelo E. BigalCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States), Albert Einstein College of Medicine, Montefiore Medical Center, Uniformed Services University of the Health Sciences
- DSDaniel Serrano
Albert Einstein College of Medicine, Montefiore Medical Center, Uniformed Services University of the Health Sciences
- DCDawn C. Buse
Albert Einstein College of Medicine, Montefiore Medical Center, Uniformed Services University of the Health Sciences
- ISI Scher
Albert Einstein College of Medicine, Montefiore Medical Center, Uniformed Services University of the Health Sciences
- WFWalter F. Stewart
Albert Einstein College of Medicine, Montefiore Medical Center, Uniformed Services University of the Health Sciences
Topics & keywords
- Triptans
- Migraine
- Medicine
- Chronic Migraine
- Population
- Logistic regression
- Internal medicine
- Longitudinal study
- Good health and well-being